多囊卵巢综合征女性个体化生活方式干预(IPOS):一项多中心随机对照试验的研究方案,评估个体化生活方式干预对希望妊娠的多囊卵巢综合征女性的有效性
IPOS 是一项在 South Asian 多囊卵巢综合征(PCOS)女性中开展的多中心、开放标签随机对照试验。计划将 BMI 在 ≥23 至 ≤35 kg/m2、不孕年限 ≤3 年、年龄 19 至 37 岁且希望妊娠的 PCOS 女性随机分为两组:A 组接受个体化饮食与运动建议、电话提醒系统及随访访视,B 组接受一次性饮食与运动建议;两组均在随机化 3 个月后于 6 个月治疗期内接受最多 3 个周期来曲唑促排卵。主要结局为干预期间受孕后的活产。
要点
- 研究对象为 South Asian 希望妊娠的 PCOS 女性,年龄 19 至 37 岁,BMI ≥23 且 ≤35 kg/m2,不孕年限 ≤3 年。
- A 组接受个体化饮食与运动建议、电话提醒系统及随访访视,B 组接受一次性饮食与运动建议。
- 两组均在随机化 3 个月后于 6 个月治疗期内接受最多 3 个周期来曲唑促排卵,主要结局为活产。
核心结论
- IPOS 试验结果可能有助于阐明并提供更稳健的证据,以倡导对希望妊娠的 PCOS 女性进行个体化生活方式干预。
研究设计与样本
- 研究设计为开放标签、多中心、随机对照试验,在 South Asian 希望妊娠的 PCOS 女性中开展。
- 计划纳入年龄 19 至 37 岁、确诊 PCOS 且希望妊娠、BMI ≥23 且 ≤35 kg/m2、不孕年限 ≤3 年的女性。
- 计划将 PCOS 女性随机分为两组:A 组接受个体化饮食与运动建议、电话提醒系统及随访访视,B 组(对照)接受一次性饮食与运动建议。
- 两组均在随机化 3 个月后于 6 个月治疗期内接受最多 3 个周期来曲唑促排卵。
主要发现
- 主要结局为干预期间受孕后的活产。
- 次要结局包括临床妊娠率、持续妊娠率、流产率、异位妊娠率、死产、妊娠时间、平均体重下降、人体测量参数差异、月经规律性改善及生活质量评分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine condition which affects women in the reproductive age group. South Asian women with PCOS have a higher risk of insulin resistance and metabolic disorder compared to women from other ethnic backgrounds. Lifestyle interventions such as dietary advice and physical exercise are recommended as a first-line management option for infertile women with PCOS. Most of the randomized controlled trials evaluating the role of lifestyle interventions in infertile PCOS women were characterized by methodological issues. The uptake of lifestyle modifications as a treatment strategy in the South Asian population is complicated by a difficult-to-change conventional high-carbohydrate diet and limited availability of space for physical activity in the region. METHODS: The study is designed as an open-label, multicentre, randomized controlled trial in South Asian women with PCOS. Women attending the fertility clinic will be screened for eligibility, and women aged between 19 and 37 years who have been diagnosed with PCOS and wishing to conceive will be invited to participate in the trial. We will include women with body mass index (BMI) between ≥ 23 and ≤ 35 kg/m2 and duration of infertility ≤ 3 years. We plan to randomize women with PCOS into two groups: group A will receive the intervention which will consist of individualized advice on diet and physical exercise along with a telephonic reminder system and follow-up visits, and group B (control) will receive one-time advice on diet and physical exercise. Both groups will receive up to three cycles of ovulation induction with letrozole after 3 months of randomization during the 6-month treatment period. The primary outcome of the trial will be the live birth following conception during the intervention period. The secondary outcomes include clinical pregnancy rate, ongoing pregnancy rate, miscarriage rate, ectopic pregnancy rate, stillbirth, time to pregnancy, mean weight loss, differences in anthropometric parameters, improvement in menstrual regularity and quality of life score. DISCUSSION: The IPOS trial results could help clarify and provide more robust evidence for advocating an individualized lifestyle intervention in PCOS women who wish to conceive. TRIAL REGISTRATION: Clinical Trial Registry of India CTRI/2023/04/051620. Registered on 13 April 2023.
引用
- Malhotra N, Arora T, Suri V, et al. Individualized lifestyle intervention in PCOS women (IPOS): a study protocol for a multicentric randomized controlled trial for evaluating the effectiveness of an individualized lifestyle intervention in PCOS women who wish to conceive. Trials. 2023. PMID: 37464435. doi:10.1186/s13063-023-07466-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。